<DOC>
<DOCNO>
EP-0000285
</DOCNO>
<TEXT>
<DATE>
19790110
</DATE>
<IPC-CLASSIFICATIONS>
<main>C07D-501/36</main> C07D-249/12 A61P-31/00 C07D-249/00 A61K-31/545 C07D-501/36 A61K-31/546 C07D-501/00 A61P-31/04 
</IPC-CLASSIFICATIONS>
<TITLE>
7-acylamino-3-((3-(carboxymethyl) thio-1 h-1,2,4-triazol-5-yl) thiomethyl)-3-cephem-4-carboxylic acid derivatives, processes for their preparation and compositions containing them.
</TITLE>
<APPLICANT>
smithkline corpus<sep>smithkline corporation<sep>smithkline beckman corporationp.o. box 7929 1 franklin plazaphiladelphia pennsylvania 19101us<sep>smithkline beckman corporation<sep>
</APPLICANT>
<INVENTOR>
berges david alan<sep>berges, david alan<sep>berges, david alan18 buckwalter roadphoenixville pennsylvania 19460us<sep>berges, david alan<sep>berges, david alan18 buckwalter roadphoenixville pennsylvania 19460us<sep>
</INVENTOR>
<ABSTRACT>
cephalosporins of the formula    in which r represents various acyl substituents;   râ€² represents hydrogen or an alkali metal salt, have anti-bacterial  activity.  they can be prepared by reacting 4,5-dihydro-5- thioxo-1h- 1,2,4- triazol-3-yl  thioacetic acid or an alkali metal salt  thereof with the corresponding 3-acetoxymethyl cephalosporin.   the thioacetic acids used as intermediates in preparing  cephalosporins of the invention are also part of the present  invention.  
</ABSTRACT>
</TEXT>
</DOC>
